Part of Thermo Fisher Scientific, Inc., Creatv MicroTech, Inc. is a company headquartered in the United States. The firm manufactures microfabrication products for x-ray and gamma-ray imaging.

Meiji Co., Ltd. produces and sells milk, dairy, confectioneries, and food. Its products include cheese, ice cream, chocolate, infant formula, whey protein, beauty supplements, and yogurt. The company was founded on December 21, 1917 and is headquartered in Tokyo, Japan.

Shulan (Hangzhou) Hospital Co., Ltd., established on 2014-12-30, Business scope includes licensed projects:medical service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Health Consulting Services(Does not include medical services);Non-Certificate Labor Occupational Skills Training for Adults(Except for projects involving pre-approval);business management;Information Consulting Service(Not including licensing information consulting services)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Hangzhou Tongchuang Medical Laboratory Co., Ltd., established on 2017-01-23, Business scope includes services:Medical Laboratory(clinical body fluid,blood specialty,clinical microbiology major,clinical chemistry laboratory,clinical immunization,Serology major,Clinical Cytomolecular Genetics Major),Pathology,Non-medical health management consultation(In addition to diagnosis and treatment),Computer hardware and software,Achievement transfer of communication products,technical consulting,Technical Services,Business Management Consulting,marketing planning,Business Consulting(Intermediary),Entrusted hospital management(Does not include medical services),computer system integration,Domestic advertising design,make,acting,release(In addition to online advertising);wholesale,retail:First,two,Class III Medical Devices,electronic product,communication equipment,Computer software and auxiliary equipment.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan.

Plexxikon, Inc. engages in the discovery and development of small molecule pharmaceuticals to treat human disease. The company's products include PLX204 for the treatment of diabetes; PLX4032 for the treatment of melanoma and colorectal cancer; and PLX5568 kinase inhibitors for the treatment of pain, polycystic kidney disease, rheumatoid arthritis, metastatic breast cancer, and renal disease. It develops a portfolio of clinical and preclinical stage programs in various therapeutic areas, including metabolic disease, such as obesity indications; oncology, such as osteolytic metastatic disease; and CNS, such as multiple sclerosis. The company’s portfolio of clinical and preclinical stage programs for other therapeutic areas include inflammation, such as systemic lupus erythematosus, inflammatory bowel disease, and osteoporosis; and cardiovascular, including hypertension and atherosclerosis.

Theraclone Sciences (formerly Spaltudaq) is a Seattle-based discovery-stage biotech focused on the development of novel therapeutic antibodies for the treatment of infectious disease and inflammation. The company's technology harnesses the power of the human immune system to identify naturally evolved monoclonal antibodies from the blood cells of immunologically relevant human subjects. Recombinant human monoclonal antibodies can be rapidly obtained using our discovery platform and scaled for large-scale industrial production. Such antibody drug candidates may be uniquely important in combating disease and may have potential as therapeutic products that can be administered to a broad patient population. Theraclone is a privately held company with venture investment from ARCH Venture Partners, Canaan Partners, Healthcare Ventures, Amgen Ventures, MPM Capital, and Alexandria Real Estate Investment.

W. L. Gore & Associates has made its name by creating innovative, technology-driven solutions, from medical devices that treat aneurysms to high-performance GORE‑TEX® fabrics. A privately held company with annual sales of more than $3 billion, Gore is committed to perpetuating its 50-plus year tradition of product innovation. Gore focuses its efforts in four main areas: electronics, fabrics, industrial and medical products. The company’s electronic products division develops and manufactures high-performance copper and optical signal transmission products. Gore’s fabrics provide protection from the elements and enable wearers to remain comfortable across a broad range of activities and conditions. The products made by Gore’s industrial division meet diverse contamination control and processing challenges throughout industry. Implants from the medical division provide creative healing solutions to complex medical problems. Today, Gore employs more than 10,000 employees, called associates, with manufacturing facilities in the United States, Germany, the United Kingdom, Japan and China, and sales offices around the world.

Immunex Corporation develops, manufactures, and markets therapeutic products for the treatment of cancer, infectious diseases, and autoimmune disorders. It offers products, such as Enbrel that is used in the treatment of rheumatoid arthritis; Novantrone, which is used to treat acute nonlymphocytic leukemia and pain associated with prostate cancer; and Leukine for use in bone marrow transplant patients. The company has franchise operations. It has a strategic alliance with American Home Products. The company was founded in 1981 and is based in Seattle, Washington. As of July 15, 2002, Immunex Corporation was acquired by Amgen, Inc.

Meiji Seika Pharma Co., Ltd. engages in the business of manufacture and distribution of pharmaceutical products. It also engages in the animal health business. The company was founded on October 9, 1916 and is headquartered in Tokyo, Japan.

ADVANCE Co. Ltd. develops and manufactures medical devices and healthcare products. It offers dental cadim, laser blood flow meter and home health care goods. The company was founded on March 26, 1973 and is headquartered in Tokyo, Japan.

Part of Shanghai RAAS Blood Products Co., Ltd., Tonrol Biological Pharmaceutical Co. Ltd. is a Chinese company located in Hefei. The firm develops blood solutions such as human serum albumin, IgG and IVIG. On December 19, 2014 Shanghai RAAS Blood Products Co., Ltd. acquired Tonrol Biological Pharmaceutical Co. Ltd. for $1,064.85 million.

Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever

Nanjing Aipeijie Biotechnology Co., Ltd., established on 2012-11-12, Business scope includes biotechnology research and development,Biomedical Technology Consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Institute of Biological Products Co., Ltd., established on 1993-09-08, Business scope includes production and sale of blood products,vaccine,Bioengineering products,medical laboratory animals;Engaged in the import and export of goods and technology;Technology development in the field of biotechnology and biological products,technology transfer,technical consulting,Technical Services. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Banyu Pharmaceutical Co. Ltd. produces and distributes pharmaceutical products. It researches, develops, manufactures, sells, and imports and exports ethical drugs in Japan. Banyu Pharmaceutical was founded in 1915 and is headquartered in Tokyo, Japan.